An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
Prochains essais cliniques
-
October University for Modern Sciences and ArtsRecrutement
-
Uskudar UniversityPas encore de recrutementDouleur musculo-squelettique | Maladies professionnellesTurquie (Türkiye)
-
Milton S. Hershey Medical CenterAxogen CorporationPas encore de recrutementCancer de la parotide | Parotidectomie | Le syndrome de Frey | Parotidectomie, résultats rapportés par les patients | Tumeur de la glande parotide
-
University of the Italian SwitzerlandUniversita di VeronaPas encore de recrutementFardeau des soignants | La détresse psychologiqueSuisse
-
Ain Shams UniversityPas encore de recrutementHip Abductor Insufficiency Following Total Hip Arthroplasty
-
University of CalgaryPas encore de recrutementHypospadias | Obstruction de la jonction urétéro-pelvienneCanada
-
Reinovax Biologics Co., LTDPas encore de recrutementA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccineMaladie infectieuse à pneumocoqueChine
-
Research IncRecrutementPostoperative Nasal Fibrosis After RhinoplastyColombie
-
Abramson Cancer Center at Penn MedicinePas encore de recrutement
-
Aligos TherapeuticsPas encore de recrutementParticipants en bonne santéÉtats-Unis
-
PT Equilab InternationalNestle IndonesiaRecrutement
-
Stanford UniversityPas encore de recrutement